Regulators

UnitedHealth and Amedisys to Mediate DOJ Merger Concerns in August
Regulatory & Compliance UnitedHealth and Amedisys to Mediate DOJ Merger Concerns in August

Context and Importance In the wake of increased regulatory scrutiny, UnitedHealth Group and Amedisys are set to enter mediation with the Department of Justice (DOJ). This mediation, focused on their $3.3 billion merger, aims to address antitrust concerns. Scheduled for August 18, the session will

How Will Medtech Navigate Tariff Challenges Under Trump?
Regulatory & Compliance How Will Medtech Navigate Tariff Challenges Under Trump?

James Maitland is an expert in robotics and IoT applications in medicine, driven by a strong passion for leveraging technology to advance healthcare solutions. He has extensive knowledge on topics like trade policies and their impact on medtech companies. In this interview, we delve into the

What Will the New Board Mean for Autocam Medical's Future?
Regulatory & Compliance What Will the New Board Mean for Autocam Medical's Future?

Autocam Medical, a leading global contract manufacturer of precision surgical and medical components, recently announced notable changes to its board of directors. James Maitland, an expert in robotics and IoT applications in medicine, shares his insights on the strategic goals of the company and

Will Trump’s Budget Cuts Reshape America's Health Programs?
Regulatory & Compliance Will Trump’s Budget Cuts Reshape America's Health Programs?

James Maitland, an expert in robotics and IoT applications in medicine, joins us today to discuss the significant changes proposed in the HHS budget. With his extensive background in leveraging technology to advance healthcare solutions, James provides valuable insights into the impact of these

Judge Blocks NIH from Capping Indirect Research Cost Funding at 15%
Regulatory & Compliance Judge Blocks NIH from Capping Indirect Research Cost Funding at 15%

A significant recent legal ruling by U.S. District Judge Angel Kelley has permanently prevented the National Institutes of Health (NIH) from capping indirect research cost funding at 15%, a move that would have caused substantial financial repercussions for research institutions. If the proposed

Will States Lose Vital Public Health Funds Post-Pandemic?
Regulatory & Compliance Will States Lose Vital Public Health Funds Post-Pandemic?

Recent developments in a high-profile legal battle have temporarily suspended the Department of Health and Human Services’ (HHS) plan to cut over $11 billion in public health funding for states. This critical decision underscores the ongoing importance of federal support for a wide array of e

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later